Parma, Italy

Christine Edwards

This inventor holds 1 USPTO granted patent and 5 published patent applications and 10 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Edwards. Retrieved from https://idiyas.com/inventor/christine-edwards-wptp31ix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Edwards - Innovator in Pharmaceutical Research

Introduction

Christine Edwards is an accomplished inventor based in Parma, Italy. She is currently associated with Chiesi Farmaceutici S.p.a., where she contributes to innovative pharmaceutical research. Although she has not yet been granted any patents, her work focuses on developing compounds that may have significant therapeutic applications.

Latest Patent Applications

Christine's latest patent applications include "Dihydrofuropyridine Derivatives as Rho-Kinase Inhibitors." This invention relates to compounds that inhibit Rho Kinase, specifically dihydrofuropyridine derivatives. The application details methods for preparing these compounds, pharmaceutical compositions containing them, and their therapeutic uses. The compounds may be particularly useful in treating various disorders associated with ROCK enzyme mechanisms, including pulmonary diseases such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH).

Conclusion

Christine Edwards is a promising inventor in the pharmaceutical field, focusing on innovative solutions for serious health conditions. Her ongoing research and patent applications reflect her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…